Stockreport

Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Tempus AI (NasdaqGS:TEM) and Daiichi Sankyo announced a collaboration to use Tempus' AI models in oncology drug development. The partnership centers on a novel antibo [Read more]